Cyclodextrin to prevent abdominal aortic aneurysm
The scientists at University of Michigan Medical Center, Ann Arbor, MI published on a new application of hydroxypropyl beta-cyclodextrin (HPβCD)
Tag: HPBCD
Cyclo Therapeutics Reports on Eighteen Month Expanded Access Program in Single Alzheimer’s Patient
Cyclo Therapeutics, Inc., a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C
Use of cyclodextrins as agrochemical delivery system
ADAMA MAKHTESHIM LTD. (Israel) filed a PCT patent application (WO2020084572) that was recently published. The invention relates to preparation and use
Cyclo Therapeutics reports international patent application for treating Alzheimer’s
Cyclo Therapeutics reported the publication of an international patent application for the treatment of Alzheimer’s disease with HPBCD.
Like soap for the patient’s mouth—cyclodextrins are important for future of oral care
Dental Tribune, the European blog of dentists published a post on the possible application of cyclodextrins as a mouth rinse
Cyclo Therapeutics announces positive safety profile of its drug Trappsol Cyclo
Cyclo Therapeutics, Inc., a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C (NPC)
Ginkgo terpenoid against COVID-19
Due to the reported high ability of virulence of COVID_19 in recent months, several studies have been conducted to discover
Solubilization and stabilization of beta-acids from hop extract by HPBCD
Hops are the flowers (also called seed cones or strobiles) of the hop plant Humulus lupulus. They are used primarily
Fast-dissolving antioxidant curcumin/cyclodextrin inclusion complex electrospun nanofibrous webs
Curcumin/Hydroxypropyl-beta-Cyclodextrin (HP-β-CD) and Curcumin/Hydroxypropyl-gamma-Cyclodextrin (HP-γ-CD) inclusion complex nanofibrous webs were produced using electrospinning technique for the purpose of orally fast-dissolving
The role of Roquette’s KLEPTOSE® HPbCD in the fight against coronavirus
Roquette has recently identified that its KLEPTOSE® hydroxypropyl beta-cyclodextrins (HPβCD) product, a functional excipient and a specialty active pharmaceutical ingredient (API),